CAS: 1264-72-8 Colistin Sulfate Powder

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: HNB-Colistin sulfate
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Colistin Sulfate
• CAS: 1264-72-8
• Molecular Weight: 1253.51
• Molecular Formula: C52h100n16o17s
• Density: 1.3±0.1 g/cm3
• Assay: HPLC99%
• Sample: 10g Available
• Factory Supply: Yes
• Usage: Animal Pharmaceuticals
• Shelf Life: 2 Years Proper Storage
• Certificate: GMP/ISO9001
• Packing: Carton Box or Drum
• Payment: Tt/Western Union
• Transport Package: Carton Box
• Specification: HPLC 99%
• Trademark: HNB
• Origin: China
• HS Code: 3006920000
• Production Capacity: 1000kg Per Month

Product Description

Cas:1264-72-8 Colistin sulfate powder

 

product name	Colistin sulfate
cas number	1264-72-8
apperance	White powder
Density	1.3±0.1 g/cm3
MF	C52H100N16O17S
MW	401.457

Colistin sulfate, also known as colistin sulfate, Colistin, Polymyxin E, polymyxin E, and antifoam, etc., white or nearly white powder, odorless, bitter in taste, hygroscopic, easy to dissolve In water, it is slightly soluble in ethanol, almost insoluble in ether, etc., and the free alkali is slightly soluble in water. Stable in the range of PH3-7.5. Colistin sulfate is produced by polymyxa bacterium, has a strong antibacterial effect on gram-negative bacteria, and is used to treat intestinal diseases caused by gram-negative bacteria. It is better to combine with sulfadiazine.
It is mainly used to treat intestinal infections caused by Gram-negative bacilli (Escherichia coli, etc.), and it is also effective against Pseudomonas aeruginosa infections (septicemia, urinary tract infection, burn or trauma wound infection).
medicine interactions
(1) Sulfonamides and Rifford can enhance the antibacterial effect of this product on Escherichia coli, Enterobacter, Pneumoniae, Pseudomonas aeruginosa, etc. (2) This product can enhance the antibacterial effect of amphotericin B on coccidioides. (3) Combined use with muscle relaxants and neuromuscular blockers (such as aminoglycoside antibiotics, etc.) may cause muscle weakness and apnea.